110 related articles for article (PubMed ID: 7624904)
1. Liquid chromatographic analysis of mesna and dimesna in plasma and urine of patients treated with mesna.
el-Yazigi A; Yusuf A; al-Rawithi S
Ther Drug Monit; 1995 Apr; 17(2):153-8. PubMed ID: 7624904
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation.
el-Yazigi A; Ernst P; al-Rawithi S; Legayada E; Raines DA
J Clin Pharmacol; 1997 Jul; 37(7):618-24. PubMed ID: 9243355
[TBL] [Abstract][Full Text] [Related]
3. Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
Verschraagen M; Zwiers TH; de Koning PE; Welink J; van der Vijgh WJ
J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):293-302. PubMed ID: 11334343
[TBL] [Abstract][Full Text] [Related]
4. Reduction of dimesna to mesna by the isolated perfused rat liver.
Goren MP; Hsu LC; Li JT
Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
[TBL] [Abstract][Full Text] [Related]
5. An expedient liquid chromatographic micromeasurement of isoniazid in plasma by use of electrochemical detection.
el-Yazigi A; Yusuf A
Ther Drug Monit; 1991 May; 13(3):254-9. PubMed ID: 1926281
[TBL] [Abstract][Full Text] [Related]
6. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
[TBL] [Abstract][Full Text] [Related]
7. Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection.
James CA; Rogers HJ
J Chromatogr; 1986 Oct; 382():394-8. PubMed ID: 3097045
[No Abstract] [Full Text] [Related]
8. Urinary mesna and total mesna measurement by high performance liquid chromatography with ultraviolet detection.
Głowacki R; Gryglik D; Kuśmierek K; Bald E
Talanta; 2005 Apr; 66(3):534-9. PubMed ID: 18970018
[TBL] [Abstract][Full Text] [Related]
9. Expedient liquid chromatographic analysis of azathioprine in plasma by use of silica solid phase extraction.
el-Yazigi A; Abdel Wahab F
Ther Drug Monit; 1992 Aug; 14(4):312-6. PubMed ID: 1325691
[TBL] [Abstract][Full Text] [Related]
10. The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
Reuther H; Kohl M; Wildenauer DB
Arzneimittelforschung; 1986 Apr; 36(4):763-5. PubMed ID: 3087373
[TBL] [Abstract][Full Text] [Related]
11. A direct liquid chromatographic quantitation of ciprofloxacin in microsamples of plasma with fluorometric detection.
el-Yazigi A; al-Rawithy S
Ther Drug Monit; 1990 Jul; 12(4):378-81. PubMed ID: 2396312
[TBL] [Abstract][Full Text] [Related]
12. Microdetermination of propofol in plasma by a rapid and sensitive liquid chromatographic method.
el-Yazigi A; Hussein RF
J Pharm Biomed Anal; 1996 Oct; 15(1):99-104. PubMed ID: 8895080
[TBL] [Abstract][Full Text] [Related]
13. Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.
Shaw IC; Weeks MS
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):933-5. PubMed ID: 3117563
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
James CA; Mant TG; Rogers HJ
Br J Clin Pharmacol; 1987 May; 23(5):561-8. PubMed ID: 3109461
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
Cutler MJ; Velenosi TJ; Bodalia A; House AA; Urquhart BL; Freeman DJ
Amino Acids; 2015 Mar; 47(3):511-23. PubMed ID: 25488427
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
[TBL] [Abstract][Full Text] [Related]
17. New investigations into the stability of Mesna using LC-MS/MS and NMR.
Salman D; Swinden J; Peron JM; Barton S; Nabhani-Gebara S
Expert Rev Anticancer Ther; 2016; 16(1):123-30. PubMed ID: 26568378
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
Brock N; Stekar J
Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna.
Cutler MJ; Urquhart BL; Velenosi TJ; Meyer Zu Schwabedissen HE; Dresser GK; Leake BF; Tirona RG; Kim RB; Freeman DJ
J Clin Pharmacol; 2012 Apr; 52(4):530-42. PubMed ID: 21505084
[TBL] [Abstract][Full Text] [Related]
20. The fate of [14C]-mesna in the rat.
Shaw IC; Graham MI; Jones MS
Arzneimittelforschung; 1986 Mar; 36(3):487-9. PubMed ID: 3085684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
